Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as against Rs 4.18 crore during the previous quarter ended June 2023. Sales rose 2.65% to Rs 43.05 crore in the quarter ended June 2024 as against Rs 41.94 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	43.05	41.94	3
OPM %	7.99	16.57	-
PBDT	3.33	6.37	-48
PBT	1.56	4.68	-67
NP	1.35	4.18	-68